Content about Specialty pharmacy

October 29, 2009
BIO responds to GPhA letter to Obama

The Biotechnology Industry Organization has asked the Obama administration and members of Congress to disregard...

October 27, 2009
Renewed lease spells renewed commitment for Accredo, Memphis community

Accredo Health has renewed the lease on its 240,000-sq.-ft. Century Center headquarters, the company announced...

October 26, 2009
FDA approves chronic lymphocytic leukemia treatment

The Food and Drug Administration has approved a new treatment for a cancer that mostly...

October 26, 2009
Hospira reports boost in Q3

An increase in specialty drugs, particularly a chemotherapy drug, caused Hospira’s third quarter 2009 profits...

October 25, 2009
FDA approves emergency use of IV drug as H1N1 treatment

The Food and Drug Administration has authorized emergency use of an intravenous drug for patients...

October 25, 2009
Third patient taking arthritis drug develops PML

A third case of a deadly brain infection has occurred in a patient using a...

October 22, 2009
Bayer, Onyx to enroll patients for thyroid cancer clinical trial

German drug maker Bayer HealthCare and partner Onyx Pharmaceuticals have started enrolling patients for a...

October 22, 2009
The Apothecary Shops appoints execs

A specialty pharmacy company that has lately expanded on a regional level now plans to...

October 21, 2009
FDA approves drug for managing plasma uric acid levels

The Food and Drug Administration has approved a new drug for managing levels of a...

October 19, 2009
Calif. health plan selects Diplomat as exclusive specialty Rx provider

The Inland Empire Health Plan in California has selected Diplomat Specialty Pharmacy to be its...

October 15, 2009
FDA approves GSK's HPV vaccine

Merck & Co.’s highly successful human papillomavirus vaccine Gardasil has a new competitor....

October 14, 2009
FDA advisory committee supports efficacy, safety data of Acorda's MS drug

A Food and Drug Administration advisory committee has given a favorable review to an investigational...

October 14, 2009
Sanofi Pasteur: Only one dose of H1N1 vaccine needed for children under 9 years old

Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, on Wednesday announced that clinical trials...

October 13, 2009
Questions raised about promising HIV vaccine trial results

The excitement over data from a late-stage clinical trial of an HIV vaccine regimen may...

October 13, 2009
Trading halted on Acorda as FDA considers new MS drug

It’s been bad news lately for Acorda Therapeutics....

October 12, 2009
FDA approves hereditary angioedema treatment

The Food and Drug Administration has approved a drug designed to treat symptoms associated with...

October 12, 2009
Novartis enters agreement for U.S., Canadian rights for schizophrenia treatment

A drug maker has entered an exclusive agreement to launch an oral therapy for the...

October 8, 2009
FDA rejects colorectal cancer treatment

The Food and Drug Administration has rejected the approval application for a drug to treat...

October 8, 2009
Late-stage clinical trial results: MS drug is effective

Patients taking an investigational drug for multiple sclerosis fared better than those taking placebo, according...

October 7, 2009
BDSI to launch pain treatment associated with cancer

A new treatment for treating breakthrough pain associated with cancer will hit the market next...

October 7, 2009
FDA advisory committee approves Pfizer's HIV treatment

A Food and Drug Administration advisory committee has recommended approval for an HIV drug as...

October 7, 2009
Medco report: Specialty pharmacy spending driven by cancer drugs

Cancer drugs will become the biggest driver of specialty pharmacy spending, with global sales of...

October 7, 2009
Sanofi Pasteur: H1N1 shot boosts immune response

Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, on Thursday announced that a single...

October 6, 2009
Sandoz launches first biosimilar

The generics arm of Swiss drug maker Novartis has launched Japan’s first biosimilar....

October 5, 2009
FDA approves 100th antiretroviral drug for PEPFAR

The Food and Drug Administration has approved the 100th antiretroviral drug under the President's Emergency...

© 2013 Drug Store News. All Rights Reserved.